394 related articles for article (PubMed ID: 8002147)
21. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
Panagiotidou D; Kousidou T; Chaidemenos G; Karakatsanis G; Kalogeropoulou A; Teknetzis A; Chatzopoulou E; Michailidis D
J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423
[TBL] [Abstract][Full Text] [Related]
22. Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Carreira A; Ferreira JB; Pereira I; Ferreira J; Filipe P; Ferreira RB; Monteiro S
J Med Microbiol; 2018 Feb; 67(2):198-207. PubMed ID: 29388537
[TBL] [Abstract][Full Text] [Related]
23. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
Solgun G; Fındık D; Türk Dağı H; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170
[TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
25. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Van Hecke E; Van Cutsem J
Mycoses; 1988 Dec; 31(12):641-9. PubMed ID: 2852776
[No Abstract] [Full Text] [Related]
26. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
[TBL] [Abstract][Full Text] [Related]
27. Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis.
Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes DC; Estivill D; Giusiano G
Antimicrob Agents Chemother; 2011 Sep; 55(9):4420-1. PubMed ID: 21746955
[TBL] [Abstract][Full Text] [Related]
28. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris.
Bourlond A; Lachapelle JM; Aussems J; Boyden B; Campaert H; Conincx S; Decroix J; Geeraerts C; Ghekiere L; Morias J
Int J Dermatol; 1989; 28(6):410-2. PubMed ID: 2548967
[TBL] [Abstract][Full Text] [Related]
29. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children.
López-Gómez S; Del Palacio A; Van Cutsem J; Soledad Cuétara M; Iglesias L; Rodriguez-Noriega A
Int J Dermatol; 1994 Oct; 33(10):743-7. PubMed ID: 8002149
[TBL] [Abstract][Full Text] [Related]
30. [Sensitivity of the arthrosporic and microconidial stages of Trichophyton mentagrophytes to griseofulvin and ketoconazole].
Buchta V
Cesk Farm; 1989 Nov; 38(9):418-20. PubMed ID: 2517558
[TBL] [Abstract][Full Text] [Related]
31. [Tinea manuum. Report of 13 cases].
Wanke NC; Wanke B
Med Cutan Ibero Lat Am; 1985; 13(6):497-501. PubMed ID: 3914602
[TBL] [Abstract][Full Text] [Related]
32. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
Barros ME; Hamdan JS
Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
[TBL] [Abstract][Full Text] [Related]
33. What defines the quality of patient care in tinea pedis?
Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
[TBL] [Abstract][Full Text] [Related]
34. Griseofulvin-resistant dermatophytosis correlates with in vitro resistance.
Artis WM; Odle BM; Jones HE
Arch Dermatol; 1981 Jan; 117(1):16-9. PubMed ID: 7458371
[TBL] [Abstract][Full Text] [Related]
35. Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients.
Mathur M; Shrestha S
JNMA J Nepal Med Assoc; 2015; 53(198):108-12. PubMed ID: 26994030
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Badali H; Mohammadi R; Mashedi O; de Hoog GS; Meis JF
Mycoses; 2015 May; 58(5):303-7. PubMed ID: 25757042
[TBL] [Abstract][Full Text] [Related]
37. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.
Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A
Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Antifungal Activity of Green Synthesized Silver Nanoparticles in Comparison to Conventional Antifungal Drugs Against Trichophyton Interdigitale, Trichophyton Rubrum and Epidermophyton Floccosum.
Mahmoudi S; Vahidi M; Malekabad ES; Izadi A; Khatami M; Dadashi A
Infect Disord Drug Targets; 2021; 21(3):370-374. PubMed ID: 32669080
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Mycoses; 1998; 41(7-8):309-19. PubMed ID: 9861837
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
